The city of Sacramento, California, currently has 2 active clinical trials seeking participants for Type 2 Diabetes research studies.
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
NCT05099770
Recruiting
The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and delivered percutaneously into biopsied and non-biopsied contralateral kidneys in participants with T2DM and CKD.
Gender:
ALL
Ages:
Between 30 years and 80 years
Trial Updated:
07/22/2025
Locations: UC Davis Medical Group GI Unit, Sacramento, California
Conditions: Type 2 Diabetes Mellitus, Chronic Kidney Diseases
Register for Updates
Use of CGM in Kidney Transplant Recipients
NCT04783441
Recruiting
The investigators want to study the impact CGM (continuous glucose monitoring) has on patients glycemic control as determined by time in range (TIR 70-180 mg/dL) in the Diabetic Kidney Transplant population.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/29/2025
Locations: UC Davis Health, Sacramento, California
Conditions: Kidney Transplant; Complications, Diabetes Mellitus, Type 2, Insulin Dependent Diabetes
Register for Updates